ACRS
ACRS
US00461U1051
Aclaris Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 7.826.000 18.720.000
58.2%
Cost of Revenue 7.284.000 15.458.000
52.9%
Gross Profit 542.000 3.262.000
83.4%
74.617.000 55.789.000
33.7%
Operating Income -74.075.000 -52.527.000
41.0%
Pretax Income -64.923.000 -132.065.000
50.8%
Net Income Common Stockholders -64.923.000 -132.065.000
50.8%
-- --
--
-- --
--
ende